Nicole Christine Nelson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nicole Christine Nelson has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Cambrosio
Department of Social Studies of Medicine, McGill University, Montreal, QC, Canada
5 shared publications Kelsey Ichikawa
5 shared publicationsJulie Chung
Radcliffe Institute for Advanced Study, Harvard University, Cambridge, MA, USA
3 shared publicationsPeter Keating
Department of History, Université du Québec à Montréal, Montreal, Canada
3 shared publications- Peter Keating
Department of History, University of Quebec at Montreal, Case Postale 8888, Succursale Centre-Ville, Montreal, QC, H3C 3P8, Canada
3 shared publications Abigail Anderson
Affiliation Midwestern University Chicago College of Osteopathic Medicine, Chicago IL, United States of America
2 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by Taylor & Francis in Science as Culture
- p. 1-16
Epistemic oligarchisation: exploring capture and concentration through science reform
The concentration and capture of personal data has attracted much attention in recent years, with scholars raising alarms about the harms of contemporary ‘data-opolies’ (Stucke, 2018), ‘data enclav...
- 11 August 2026
- Published by Taylor & Francis in Science as Culture
- p. 1-16
Open AccessEpistemic oligarchisation: exploring capture and concentration through science reform
The concentration and capture of personal data has attracted much attention in recent years, with scholars raising alarms about the harms of contemporary ‘data-opolies’ (Stucke, 2018), ‘data enclav...
- Open Access
- 18 June 2026
- Published by Cambridge University Press (CUP) in BJHS Themes
- p. 1-19
The regulatory ethos in science
This paper introduces the concept of the regulatory ethos to describe some common values and ideals that underscore the close connection between validation and regulation that this issue of BJHS Themes explores. We identify the primary motivation for this ethos as making knowledge production processes traceable, and define the regulatory ethos as valuing plans over situated actions, uniformity over heterogeneity, auditing over communication, and validation over validity. Standard operating procedures, reporting checklists, preregistrations, compliance rules and monitoring are key means through which this ethos is enacted. While regulators have been instrumental in promulgating this ethos, it is not confined to the regulatory sphere. We argue that reforms aimed at enhancing rigour and reproducibility are an example of how the practices and values associated with regulatory science have diffused out into academic science. Identifying this ethos as regulatory in origin – rather than wholly new or as part of a broader process of modernization – allows us to see that alternatives are not unscientific per se, and better identify the strengths and weaknesses of the regulatory ethos of science, such as the risk that data produced through these procedures will be replicable, statistically rigorous, and transparent, but not meaningful.
- 18 June 2026
- Published by Cambridge University Press (CUP) in BJHS Themes
- p. 1-19
Open AccessThe regulatory ethos in science
This paper introduces the concept of the regulatory ethos to describe some common values and ideals that underscore the close connection between validation and regulation that this issue of BJHS Themes explores. We identify the primary motivation for this ethos as making knowledge production processes traceable, and define the regulatory ethos as valuing plans over situated actions, uniformity over heterogeneity, auditing over communication, and validation over validity. Standard operating procedures, reporting checklists, preregistrations, compliance rules and monitoring are key means through which this ethos is enacted. While regulators have been instrumental in promulgating this ethos, it is not confined to the regulatory sphere. We argue that reforms aimed at enhancing rigour and reproducibility are an example of how the practices and values associated with regulatory science have diffused out into academic science. Identifying this ethos as regulatory in origin – rather than wholly new or as part of a broader process of modernization – allows us to see that alternatives are not unscientific per se, and better identify the strengths and weaknesses of the regulatory ethos of science, such as the risk that data produced through these procedures will be replicable, statistically rigorous, and transparent, but not meaningful.
- Open Access
- 7 November 2025
- Published by JOTE Publishers
Cultures of Trial and Error: Field-specific Barriers to Performing Replications
In this piece, we call for more comparative research on field-specific replication dynamics.
- 7 November 2025
- Published by JOTE Publishers
Open AccessCultures of Trial and Error: Field-specific Barriers to Performing Replications
In this piece, we call for more comparative research on field-specific replication dynamics.
- Open Access
- 29 October 2025
- Published by Center for Open Science in MetaArXiv
Adversarial reanalysis and the challenge of open data in regulatory science
Over the last decade, the transparency of the scientific data supporting environmental regulations has been the subject of partisan conflict at the highest levels of the United States’ government. Recent attempts by conservatives, industry groups, and dissident scientists to promulgate transparency requirements for such data have been described by partisan opponents and critical data studies scholars alike as ‘Trojan Horses’ designed to exclude nonreplicable studies from environmental decision making. However, if we distinguish between replication (performing a study de novo) and reanalysis (re-examining data from an existing study to confirm or challenge its conclusions), several things become clear. First, these recent clashes are part of a long story, stretching back at least to the 1990s, that is centered on data access for reanalysis: while some actors may be interested in preventing the consideration of certain data, others are interested in reanalyzing data to re-examine the scientific consensus, and in fact have done so. Second, using procedure or methodological quality to adjudicate reanalyses often fails, leading to a recourse to reputational markers that amplifies rather than resolves the lack of epistemic closure. Because the transparency of regulatory data has been a bipartisan priority over the last few decades, we anticipate that adversarial reanalyses will only become more common. The aim of transparent, open scientific data is a laudable one, but as data become more open, advocates, scientists, and policymakers alike will have to be mindful of how to make decisions in the absence of scientific consensus.
- 29 October 2025
- Published by Center for Open Science in MetaArXiv
Open AccessAdversarial reanalysis and the challenge of open data in regulatory science
Over the last decade, the transparency of the scientific data supporting environmental regulations has been the subject of partisan conflict at the highest levels of the United States’ government. Recent attempts by conservatives, industry groups, and dissident scientists to promulgate transparency requirements for such data have been described by partisan opponents and critical data studies scholars alike as ‘Trojan Horses’ designed to exclude nonreplicable studies from environmental decision making. However, if we distinguish between replication (performing a study de novo) and reanalysis (re-examining data from an existing study to confirm or challenge its conclusions), several things become clear. First, these recent clashes are part of a long story, stretching back at least to the 1990s, that is centered on data access for reanalysis: while some actors may be interested in preventing the consideration of certain data, others are interested in reanalyzing data to re-examine the scientific consensus, and in fact have done so. Second, using procedure or methodological quality to adjudicate reanalyses often fails, leading to a recourse to reputational markers that amplifies rather than resolves the lack of epistemic closure. Because the transparency of regulatory data has been a bipartisan priority over the last few decades, we anticipate that adversarial reanalyses will only become more common. The aim of transparent, open scientific data is a laudable one, but as data become more open, advocates, scientists, and policymakers alike will have to be mindful of how to make decisions in the absence of scientific consensus.
- Open Access
- 20 May 2025
- Published by Center for Open Science in MetaArXiv
Adversarial reanalysis and the challenge of open data in regulatory science
Over the last decade, the transparency of the scientific data supporting environmental regulations has been the subject of partisan conflict at the highest levels of the United States’ government. Recent attempts by conservatives, industry groups, and dissident scientists to promulgate transparency requirements for such data have been described by partisan opponents and critical data studies scholars alike as ‘Trojan Horses’ designed to exclude nonreplicable studies from environmental decision making. However, if we distinguish between replication (performing a study de novo) and reanalysis (re-examining data from an existing study to confirm or challenge its conclusions), several things become clear. First, these recent clashes are part of a long story, stretching back at least to the 1990s, that is centered on data access for reanalysis: while some actors may be interested in preventing the consideration of certain data, others are interested in reanalyzing data to re-examine the scientific consensus, and in fact have done so. Second, using procedure or methodological quality to adjudicate reanalyses often fails, leading to a recourse to reputational markers that amplifies rather than resolves the lack of epistemic closure. Because the transparency of regulatory data has been a bipartisan priority over the last few decades, we anticipate that adversarial reanalyses will only become more common. The aim of transparent, open scientific data is a laudable one, but as data become more open, advocates, scientists, and policymakers alike will have to be mindful of how to make decisions in the absence of scientific consensus.
- 20 May 2025
- Published by Center for Open Science in MetaArXiv
Open AccessAdversarial reanalysis and the challenge of open data in regulatory science
Over the last decade, the transparency of the scientific data supporting environmental regulations has been the subject of partisan conflict at the highest levels of the United States’ government. Recent attempts by conservatives, industry groups, and dissident scientists to promulgate transparency requirements for such data have been described by partisan opponents and critical data studies scholars alike as ‘Trojan Horses’ designed to exclude nonreplicable studies from environmental decision making. However, if we distinguish between replication (performing a study de novo) and reanalysis (re-examining data from an existing study to confirm or challenge its conclusions), several things become clear. First, these recent clashes are part of a long story, stretching back at least to the 1990s, that is centered on data access for reanalysis: while some actors may be interested in preventing the consideration of certain data, others are interested in reanalyzing data to re-examine the scientific consensus, and in fact have done so. Second, using procedure or methodological quality to adjudicate reanalyses often fails, leading to a recourse to reputational markers that amplifies rather than resolves the lack of epistemic closure. Because the transparency of regulatory data has been a bipartisan priority over the last few decades, we anticipate that adversarial reanalyses will only become more common. The aim of transparent, open scientific data is a laudable one, but as data become more open, advocates, scientists, and policymakers alike will have to be mindful of how to make decisions in the absence of scientific consensus.
- Open Access
- 15 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0293584
Experience of irreproducibility as a risk factor for poor mental health in biomedical science doctoral students: A survey and interview-based study
High rates of irreproducibility and of poor mental health in graduate students have been reported in the biomedical sciences in the past ten years, but to date, little research has investigated whether these two trends interact. In this study, we ask whether the experience of failing to replicate an expected finding impacts graduate students’ mental health. Using an online survey paired with semi-structured qualitative interviews, we examined how often biomedical science doctoral students at a large American public university experienced events that could be interpreted as failures to replicate and how they responded to these experiences. We found that almost all participants had experience with irreproducibility: 84% had failed to replicate their own results, 70% had failed to replicate a colleague’s finding, and 58% had failed to replicate a result from the published literature. Participants reported feelings of self-doubt, frustration, and depression while experiencing irreproducibility, and in 24% of cases, these emotional responses were strong enough to interfere with participants’ eating, sleeping, or ability to work. A majority (82%) of participants initially believed that the anomalous results could be attributed to their own error. However, after further experimentation, most participants concluded that the original result was wrong (38%), that there was a key difference between the original experiment and their own (17%), or that there was a problem with the protocol (17%). These results suggest that biomedical science graduate students may be biased towards initially interpreting failures to replicate as indicative of a lack of skill, which may trigger or perpetuate feelings of anxiety, depression, or impostorism.
- 15 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0293584
Open AccessExperience of irreproducibility as a risk factor for poor mental health in biomedical science doctoral students: A survey and interview-based study
High rates of irreproducibility and of poor mental health in graduate students have been reported in the biomedical sciences in the past ten years, but to date, little research has investigated whether these two trends interact. In this study, we ask whether the experience of failing to replicate an expected finding impacts graduate students’ mental health. Using an online survey paired with semi-structured qualitative interviews, we examined how often biomedical science doctoral students at a large American public university experienced events that could be interpreted as failures to replicate and how they responded to these experiences. We found that almost all participants had experience with irreproducibility: 84% had failed to replicate their own results, 70% had failed to replicate a colleague’s finding, and 58% had failed to replicate a result from the published literature. Participants reported feelings of self-doubt, frustration, and depression while experiencing irreproducibility, and in 24% of cases, these emotional responses were strong enough to interfere with participants’ eating, sleeping, or ability to work. A majority (82%) of participants initially believed that the anomalous results could be attributed to their own error. However, after further experimentation, most participants concluded that the original result was wrong (38%), that there was a key difference between the original experiment and their own (17%), or that there was a problem with the protocol (17%). These results suggest that biomedical science graduate students may be biased towards initially interpreting failures to replicate as indicative of a lack of skill, which may trigger or perpetuate feelings of anxiety, depression, or impostorism.
- 24 February 2023
- Published by SAGE Publications in Social Studies of Science
- Vol. 53 (2) , 174-179
On first reading Bruno Latour
- 24 February 2023
- Published by SAGE Publications in Social Studies of Science
- Vol. 53 (2) , 174-179
On first reading Bruno Latour
- Open Access
- 23 August 2022
- Published by Center for Open Science in MetaArXiv
Experience of irreproducibility as a risk factor for poor mental health in biomedical science doctoral students: A survey and interview-based study
High rates of irreproducibility and of poor mental health in graduate students have been reported in the biomedical sciences in the past ten years, but to date, little research has investigated whether these two trends interact. In this study, we ask whether the experience of failing to replicate an expected finding impacts graduate students’ mental health. Using an online survey paired with semi-structured qualitative interviews, we examined how often doctoral students at a large American public university experienced events that could be interpreted as failures to replicate and how they responded to these experiences. We found that almost all participants had experience with irreproducibility: 84% had failed to replicate their own results, 70% had failed to replicate a colleague’s finding, and 58% had failed to replicate a result from the published literature. A majority (82%) of participants initially believed that the anomalous results could be attributed to their own error. However, after further experimentation, most participants concluded that the original result was wrong (38%), that there was a key difference between the original experiment and their own (17%), or that there was a problem with the protocol (17%). Participants reported feelings of self-doubt, frustration, and depression while experiencing irreproducibility, and in 24% of cases, these emotional responses were strong enough to interfere with participants’ eating, sleeping, or ability to work. These results suggest that biomedical science graduate students may be biased towards initially interpreting failures to replicate as indicative of a lack of skill, which may trigger or perpetuate feelings of anxiety, depression, or impostorism.
- 23 August 2022
- Published by Center for Open Science in MetaArXiv
Open AccessExperience of irreproducibility as a risk factor for poor mental health in biomedical science doctoral students: A survey and interview-based study
High rates of irreproducibility and of poor mental health in graduate students have been reported in the biomedical sciences in the past ten years, but to date, little research has investigated whether these two trends interact. In this study, we ask whether the experience of failing to replicate an expected finding impacts graduate students’ mental health. Using an online survey paired with semi-structured qualitative interviews, we examined how often doctoral students at a large American public university experienced events that could be interpreted as failures to replicate and how they responded to these experiences. We found that almost all participants had experience with irreproducibility: 84% had failed to replicate their own results, 70% had failed to replicate a colleague’s finding, and 58% had failed to replicate a result from the published literature. A majority (82%) of participants initially believed that the anomalous results could be attributed to their own error. However, after further experimentation, most participants concluded that the original result was wrong (38%), that there was a key difference between the original experiment and their own (17%), or that there was a problem with the protocol (17%). Participants reported feelings of self-doubt, frustration, and depression while experiencing irreproducibility, and in 24% of cases, these emotional responses were strong enough to interfere with participants’ eating, sleeping, or ability to work. These results suggest that biomedical science graduate students may be biased towards initially interpreting failures to replicate as indicative of a lack of skill, which may trigger or perpetuate feelings of anxiety, depression, or impostorism.
- 23 September 2021
- Published by SAGE Publications in Review of General Psychology
- Vol. 26 (2) , 184-198
Psychology Exceptionalism and the Multiple Discovery of the Replication Crisis
This article outlines what we call the “narrative of psychology exceptionalism” in commentaries on the replication crisis: many thoughtful commentaries link the current crisis to the specificity of psychology’s history, methods, and subject matter, but explorations of the similarities between psychology and other fields are comparatively thin. Historical analyses of the replication crisis in psychology further contribute to this exceptionalism by creating a genealogy of events and personalities that shares little in common with other fields. We aim to rebalance this narrative by examining the emergence and evolution of replication discussions in psychology alongside their emergence and evolution in biomedicine. Through a mixed-methods analysis of commentaries on replication in psychology and the biomedical sciences, we find that these conversations have, from the early years of the crisis, shared a common core that centers on concerns about the effectiveness of traditional peer review, the need for greater transparency in methods and data, and the perverse incentive structure of academia. Drawing on Robert Merton’s framework for analyzing multiple discovery in science, we argue that the nearly simultaneous emergence of this narrative across fields suggests that there are shared historical, cultural, or institutional factors driving disillusionment with established scientific practices.
- 23 September 2021
- Published by SAGE Publications in Review of General Psychology
- Vol. 26 (2) , 184-198
Psychology Exceptionalism and the Multiple Discovery of the Replication Crisis
This article outlines what we call the “narrative of psychology exceptionalism” in commentaries on the replication crisis: many thoughtful commentaries link the current crisis to the specificity of psychology’s history, methods, and subject matter, but explorations of the similarities between psychology and other fields are comparatively thin. Historical analyses of the replication crisis in psychology further contribute to this exceptionalism by creating a genealogy of events and personalities that shares little in common with other fields. We aim to rebalance this narrative by examining the emergence and evolution of replication discussions in psychology alongside their emergence and evolution in biomedicine. Through a mixed-methods analysis of commentaries on replication in psychology and the biomedical sciences, we find that these conversations have, from the early years of the crisis, shared a common core that centers on concerns about the effectiveness of traditional peer review, the need for greater transparency in methods and data, and the perverse incentive structure of academia. Drawing on Robert Merton’s framework for analyzing multiple discovery in science, we argue that the nearly simultaneous emergence of this narrative across fields suggests that there are shared historical, cultural, or institutional factors driving disillusionment with established scientific practices.
- Open Access
- 9 July 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (7) , e0254090
Mapping the discursive dimensions of the reproducibility crisis: A mixed methods analysis
To those involved in discussions about rigor, reproducibility, and replication in science, conversation about the “reproducibility crisis” appear ill-structured. Seemingly very different issues concerning the purity of reagents, accessibility of computational code, or misaligned incentives in academic research writ large are all collected up under this label. Prior work has attempted to address this problem by creating analytical definitions of reproducibility. We take a novel empirical, mixed methods approach to understanding variation in reproducibility discussions, using a combination of grounded theory and correspondence analysis to examine how a variety of authors narrate the story of the reproducibility crisis. Contrary to expectations, this analysis demonstrates that there is a clear thematic core to reproducibility discussions, centered on the incentive structure of science, the transparency of methods and data, and the need to reform academic publishing. However, we also identify three clusters of discussion that are distinct from the main body of articles: one focused on reagents, another on statistical methods, and a final cluster focused on the heterogeneity of the natural world. Although there are discursive differences between scientific and popular articles, we find no strong differences in how scientists and journalists write about the reproducibility crisis. Our findings demonstrate the value of using qualitative methods to identify the bounds and features of reproducibility discourse, and identify distinct vocabularies and constituencies that reformers should engage with to promote change.
- 9 July 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (7) , e0254090
Open AccessMapping the discursive dimensions of the reproducibility crisis: A mixed methods analysis
To those involved in discussions about rigor, reproducibility, and replication in science, conversation about the “reproducibility crisis” appear ill-structured. Seemingly very different issues concerning the purity of reagents, accessibility of computational code, or misaligned incentives in academic research writ large are all collected up under this label. Prior work has attempted to address this problem by creating analytical definitions of reproducibility. We take a novel empirical, mixed methods approach to understanding variation in reproducibility discussions, using a combination of grounded theory and correspondence analysis to examine how a variety of authors narrate the story of the reproducibility crisis. Contrary to expectations, this analysis demonstrates that there is a clear thematic core to reproducibility discussions, centered on the incentive structure of science, the transparency of methods and data, and the need to reform academic publishing. However, we also identify three clusters of discussion that are distinct from the main body of articles: one focused on reagents, another on statistical methods, and a final cluster focused on the heterogeneity of the natural world. Although there are discursive differences between scientific and popular articles, we find no strong differences in how scientists and journalists write about the reproducibility crisis. Our findings demonstrate the value of using qualitative methods to identify the bounds and features of reproducibility discourse, and identify distinct vocabularies and constituencies that reformers should engage with to promote change.